- Name
- Description
- Cat#
- Pricings
- Quantity
Catalogue number
HSV-227
Introduction
Entry of HSV into the host cell involves interactions of several viral glycoproteins with cell surface receptors. The virus particle is covered by an envelope which, when bound to specific receptors on the cell surface, will fuse with the cell membrane and create an opening, or pore, through which the virus enters the host cell. The sequential stages of HSV entry are analagous to those of other viruses. At first, complementary receptors on the virus and cell surface bring the two membranes into proximity. In an intermediate state, the two membranes begin to merge, forming a hemifusion state. Finally, a stable entry pore is formed through which the viral envelope contents are introduced to the host cell.
Description
The E.Coli derived HSV-2 VP13/14 recombinant protein, 1-280 amino acids, is fused to a Six histidine tag at C-terminus and has a MW of 31kDa (pI 6.77).
Source
Escherichia Coli.
Purity
Protein is >90% pure as determined by SDS PAGE.
Physical Appearance
Sterile Filtered clear solution.
Formulation
10 mM Phosphate buffer pH 7.6; 75 mM NaCl.
Stability
HSV-2 VP13/14 although stable at 4°C for 1 week, should be stored below -18°C.
Please prevent freeze thaw cycles.
Applications
ELISA, WB, Flow-Through.
Safety Data Sheet
Usage
ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.